Articles

This is a premium feature, offered on AllPennyStocks.com Pro. Rest assured, there is a free method to view this page.

Become A Free Member :

  • Access to two (2) free Pro articles per thirty (30) day period.
  • No archive / past result access.
  • No email / push notifications.
Free Member Registration

Become A Pro Member ($):

  • Unlimited access to all Pro articles / features.
  • Full access to archives / past results.
  • Email / push notifications customized to user preferences.
Pro Member Registration

This Biotech Rallying on New Brain Cancer Drug

Tuesday, June 21, 2022

Investment Risk Rating: High

Trade Duration:
Short Term (1 day to several months)

Trading Strategy:
Technical Analysis Focus With Brief Fundamental Analysis Review

The Under $0.25 momentum plays feature highlights penny stocks trading under $0.25 per share with strong near term upside potential ...
 More
Hide
The Under $0.25 momentum plays feature highlights penny stocks trading under $0.25 per share with strong near term upside potential. They are highly speculative and meant to be short term trades. This feature is updated twice per month and recommended only for investors that have a high risk tolerance as low priced penny stocks are highly volatile investments.

We like biotech. We've always liked biotech. But, we haven't been able to do a lot with biotech as far as trades in the last year or so as the industry has struggled for a number of reasons, including political pressures and plenty of negative press about the high price of drugs. To that end, most biotechs have seen their valuations heavily slashed.

Most Popular


Back to Top